TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05529394 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT06420089 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT06209268 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT06209268 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06725875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06288529 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02054559 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06656702 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04597853 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06179524 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05574920 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05930613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04966845 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT04869358 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04869358 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06209567 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06478342 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT06478342 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06244992 — Predictive Biomarker (PRD): ALPK1 mRNA
Genes: ALPK1; KIAA1527; LAK
Study NCT04803643 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04589650 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT06593496 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06727487 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05911295 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05523947 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05096221 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05440851 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study NCT06209853 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06658873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05331326 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05331326 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT05331326 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06670963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06670963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06672068 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05043922 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05414890 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT05512143 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05085171 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06371638 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06671379 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06671379 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04335682 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06256328 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06256328 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05416944 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06000033 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06000033 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04807777 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05419973 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT05419973 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04780334 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05381545 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05381545 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06731192 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06733597 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06754995 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT06753370 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06752941 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05052021 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06115616 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06465953 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06549790 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04827901 — Predictive Biomarker (PRD): KCNQ2 mRNA
Genes: KCNQ2
Study NCT05646888 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04743791 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT05734638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06751888 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05488145 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05488145 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06081153 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06081153 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04769258 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06752174 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06752382 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06279169 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06753591 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study NCT06239389 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT06180031 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06515613 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT06144970 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04935073 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05338970 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05338970 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03520751 — Predictive Biomarker (PRD): NTF3 mRNA
Genes: NTF3
Study NCT03520751 — Pharmacodynamic Biomarker (PDY): Peripheral myelin protein 22
Genes: PMP22; GAS3
Study NCT05554315 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06598436 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06577571 — Predictive Biomarker (PRD): CKM mRNA
Genes: CKM; CKMM
Study NCT05937295 — Predictive Biomarker (PRD): DNAJB1 mRNA
Genes: DNAJB1; DNAJ1; HDJ1; HSPF1
Study NCT05937295 — Predictive Biomarker (PRD): PRKACA mRNA
Genes: PRKACA; PKACA
Study NCT05993897 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05874895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06319365 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05543980 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06708572 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT06729827 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06113458 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06144463 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04780568 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05604482 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05604482 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT06421155 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study NCT04749251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03344276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03344276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06088459 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT06161519 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT06161519 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT06457451 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06426953 — Predictive Biomarker (PRD): MAP6 mRNA
Genes: MAP6; KIAA1878
Study NCT06426953 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT05171686 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04052243 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04052243 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05476627 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06229145 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05719454 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05782361 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05908032 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05908032 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05725291 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT05294510 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05560243 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT05552300 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05003466 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04985721 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04985721 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04985721 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05010096 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04864249 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05714917 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06300229 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05923840 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05712070 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT04872192 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05131269 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT05131269 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT05131269 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT05991531 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05217641 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05370300 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT05370300 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT05559801 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06297291 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06584357 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05852301 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05477563 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05600686 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05941494 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05649020 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05629702 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05449431 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05702814 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05245071 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06724289 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT06723795 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06378996 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT06290596 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06722625 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05839691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05993481 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05792540 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05101018 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06531577 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06242392 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT04862351 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06040593 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06040593 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05612503 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06394232 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT06394232 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05557513 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06730373 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05112653 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05112653 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05198102 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05792618 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06295393 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06724991 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06733922 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study NCT06573034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05108818 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06732336 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06732232 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06732232 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06732232 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06069310 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study NCT06164574 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06218654 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT06218654 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06218654 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT06752408 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06454032 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT06325384 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05540925 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06387212 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05525403 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT05518617 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05518617 — Predictive Biomarker (PRD): PINK1 mRNA
Genes: PINK1
Study NCT05007925 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05721482 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04717531 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04717531 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05865132 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04818619 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04529967 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04099966 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05182788 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04974372 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04974372 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT04886726 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06460753 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06460753 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06754813 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06196827 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT04580927 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05939232 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT05174936 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05101148 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06487429 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05528419 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06533059 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT06692738 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06754878 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04935528 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05608408 — Predictive Biomarker (PRD): EPHA1 mRNA
Genes: EPHA1; EPH; EPHT; EPHT1
Study NCT06427421 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06427421 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT05070585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04909489 — Predictive Biomarker (PRD): PHGDH mRNA
Genes: PHGDH; PGDH3
Study NCT04909489 — Predictive Biomarker (PRD): PSAT1 mRNA
Genes: PSAT1; PSA
Study NCT04909489 — Predictive Biomarker (PRD): PSPH mRNA
Genes: PSPH
Study NCT06392724 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06754306 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05566795 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06361381 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT06361381 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05595031 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05033951 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05033951 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05871684 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05871684 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06330012 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04645225 — Predictive Biomarker (PRD): MEFV mRNA
Genes: MEFV; MEF; TRIM20
Study NCT05841992 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05750290 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05750290 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05750290 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT05750290 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00036387 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06381947 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06381947 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05253287 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT06188429 — Predictive Biomarker (PRD): TREM2 mRNA
Genes: TREM2
Study NCT06050733 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05873764 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05029232 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00000779 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04947462 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05139992 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04847791 — Safety Biomarker (SAF): Lactotransferrin
Genes: LTF; GIG12; LF
Study NCT06571838 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05849649 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04939805 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04838457 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05906043 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06524856 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06237205 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05303428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05494593 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study NCT05148962 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05045261 — Predictive Biomarker (PRD): TLR8 mRNA
Genes: TLR8; UNQ249/PRO286
Study NCT04579523 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT00175110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05824130 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06642207 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT06642207 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06642207 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1